Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
2.
Ann Hematol ; 95(7): 1043-50, 2016 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-27106701

RESUMEN

Familial aggregation of hematological malignancies has been reported highlighting inherited genetic predisposition. In this study, we targeted four candidate genes: JAK2 and RUNX1 genes assuring a prominent function in hematological process and CBL and NPM1 as proto-oncogenes. Their disruption was described in several sporadic hematological malignancies. The aim of this study is to determine whether JAK2, CBL, RUNX1, and NPM1 germline genes mutations are involved in familial hematological malignancies. Using direct sequencing, we analyzed JAK2 (exons 12 and 14); CBL (exons 7, 8 and 9); NPM1 (exon 12) and the entire RUNX1 in 88 independent families belonging to Tunisian and French populations. Twenty-one sporadic acute leukemias were included in this study. We reported a heterozygous intronic c.1641 + 6 T > C JAK2 variant (rs182123615) found in two independent familial cases diagnosed with gastric lymphoma and Hodgkin lymphoma. The in silico analysis suggested a potential impact on splicing, but the functional splicing minigene reporter assay on rs182123615 variant showed no aberrant transcripts. In one sporadic acute myeloblastic leukemia, we reported an insertion 846 in. TGTT in exon 12 of NPM1 gene that may impact the normal reading frame. The rs182123615 JAK2 variant was described in several contexts including myeloproliferative neoplasms and congenital erythrocytosis and was supposed to be pathogenic. Through this current study, we established the assessment of pathogenicity of rs182123615 and we classified it rather as rare polymorphism.


Asunto(s)
Subunidad alfa 2 del Factor de Unión al Sitio Principal/genética , Análisis Mutacional de ADN/métodos , Neoplasias Hematológicas/genética , Janus Quinasa 2/genética , Proteínas Nucleares/genética , Proteínas Proto-Oncogénicas c-cbl/genética , Adolescente , Adulto , Anciano , Estudios de Cohortes , Femenino , Variación Genética/genética , Neoplasias Hematológicas/diagnóstico , Humanos , Masculino , Persona de Mediana Edad , Nucleofosmina , Linaje
3.
Tunis Med ; 81(1): 5-10, 2003 Jan.
Artículo en Francés | MEDLINE | ID: mdl-12708185

RESUMEN

The incidence of malignancies has increased in conjunction with epidemic of human immunodeficiency virus (HIV) disease and they are currently considered acquired immunodeficiency syndrome (AIDS)-defining conditions. Approximately 40% of all patients with AIDS have developed cancer during the course of HIV infections. Further, as survival has improved in HIV disease, the incidence of these malignancies has increased. The main malignancies noted are Kaposi's sarcoma, non-Hodgkin's lymphoma, Hodgkin's disease, rectal and anal cancer.


Asunto(s)
Neoplasias del Ano/patología , Infecciones por VIH/complicaciones , Enfermedad de Hodgkin/patología , Linfoma no Hodgkin/patología , Neoplasias del Recto/patología , Sarcoma de Kaposi/patología , Neoplasias del Ano/epidemiología , Neoplasias del Ano/etiología , Enfermedad de Hodgkin/epidemiología , Enfermedad de Hodgkin/etiología , Humanos , Incidencia , Linfoma no Hodgkin/epidemiología , Linfoma no Hodgkin/etiología , Neoplasias del Recto/epidemiología , Neoplasias del Recto/etiología , Sarcoma de Kaposi/epidemiología , Sarcoma de Kaposi/etiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA